Necrotic enteritis (NE), a disease caused by Clostridium perfringens, is economically important to the poultry industry worldwide. NE is characterized by inflammation and necrosis of the intestinal tract, resulting in a decrease in production performance
Butyrate is known as a safe alternative to antibiotics which received a wide attention in poultry industry , so phileopharma has developed a new formulations of butyrate with a specific protecting process which allowing an effective use of butyric acid along the gastrointestintal tract , Butassan plus, Butassan 70, Butassan liquid, Butassn liquid cu, Butassan E
Butassan Plus is a unique formula of sustained release sodium butyrate with a unique protecting process from phileopharma which allowing an effective sustained releasing of sodium butyrate along the gastrointestinal tract till hind gut ,promoting sufficient use of butyric acid.
Reduces the incidence of enteric diseases
Presents bactericidal effect against gram positive and gram negative bacteria
Serves as a primary energy source for development of enterocytes
Improves intestinal barrier and reduces permeability by regulating tight junctions
Modulates immune response and promotes tissue repair
Improves FCR and growth rate
Improves EPI
Increases profitability
At PhileoPharma®, our key strengths lie in our implicating technology that is a first of kind on Africa and Middle east and technical expertise developed over more than 30 years.
PhileoPharma® is innovative company aiming to develop and improve animal health products, alternatives to antibiotics and substituting any material that comprise both animal and consequently human health.
If you have a question about our products or services, or just want more information, fill out the form below and someone on our team will be in contact with you.